Projects per year
Abstract
This paper discusses the risk of gross negligence manslaughter (GNM) and corporate manslaughter charges (CM) when clinicians use an artificially intelligent system’s (AIS’s) outputs in their practice. I identify the elements of these offenses within the context of the law of England and Wales and explore how they could be applied in a potential scenario where a patient's death has followed AIS use by a clinician. The risk of a conviction due to making an AIS-augmented workplace mistake highlights the non-trivial nature of AIS adoption in healthcare, and that the consequences of its use must be considered by all interested parties prior to AIS adoption.
| Original language | English |
|---|---|
| Number of pages | 15 |
| Journal | The New Bioethics: A Multidisciplinary Journal of Biotechnology and the Body |
| Early online date | 22 Oct 2024 |
| DOIs | |
| Publication status | E-pub ahead of print - 22 Oct 2024 |
Bibliographical note
Publisher Copyright:© 2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
Fingerprint
Dive into the research topics of 'Artificial Intelligence for Clinical Decision-Making: Gross Negligence Manslaughter and Corporate Manslaughter'. Together they form a unique fingerprint.Projects
- 1 Finished
-
UKRI Trustworthy Autonomous Systems Node In Functionality
Windsor, S. P. (Principal Investigator), Ives, J. C. S. (Co-Investigator), Downer, J. R. (Co-Investigator), Rossiter, J. M. (Co-Investigator), Eder, K. I. (Co-Investigator) & Hauert, S. (Co-Investigator)
1/11/20 → 30/04/24
Project: Research, Parent